Clare is a Senior Research Fellow at the Peter MacCallum Cancer Centre. Her current research interests are in understanding the interaction between the immune system and cancer, and in the use of immunotherapy to treat cancer. These interests include the use of genetically modified T cells (CAR T-cells) to treat solid cancers. Clare has published over 40 papers in high-impact journals including first and last authorships in Nature Medicine, Proceedings of the National Academy of Sciences (PNAS), Cancer Research, Clinical Cancer Research and Cancer Discovery. Her accomplishments have been acknowledged with a number of awards including the Seymour and Vivian Milstein Young Investigator Award for notable contributions to basic and clinical research in Switzerland, a Joseph Sambrook Award in Research Excellence, and the respected Mavis Robertson Award that is given each year to a female principal investigator considered to exhibit the greatest promise as a leader in breast cancer research in Australia. In 2021, a spinout company Currus Biologics was formed based on Clare’s research that has attracted an AUD$10 million serial A investment.